1. Home
  2. KN vs ARQT Comparison

KN vs ARQT Comparison

Compare KN & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knowles Corporation

KN

Knowles Corporation

HOLD

Current Price

$39.82

Market Cap

3.0B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$24.57

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KN
ARQT
Founded
1946
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
KN
ARQT
Price
$39.82
$24.57
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$28.00
$34.00
AVG Volume (30 Days)
906.7K
1.6M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
118.94
88.79
EPS
0.11
N/A
Revenue
$593,200,000.00
$376,072,000.00
Revenue This Year
$9.40
$34.85
Revenue Next Year
$6.98
$29.39
P/E Ratio
$365.82
N/A
Revenue Growth
7.17
91.34
52 Week Low
$16.78
$13.06
52 Week High
$40.24
$31.77

Technical Indicators

Market Signals
Indicator
KN
ARQT
Relative Strength Index (RSI) 63.67 66.61
Support Level $23.97 $22.41
Resistance Level $39.92 $25.25
Average True Range (ATR) 1.69 0.94
MACD -0.07 0.48
Stochastic Oscillator 88.13 85.49

Price Performance

Historical Comparison
KN
ARQT

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: